Neonatal TPN IV Bags Recalled Due to Lack of Sterility Assurance
Central Admixture Pharmacy Services is recalling 92 bags of neonatal TPN IV bags (lot 36-262161) because of inadequate validation of manufacturing sanitization processes. The affected product was distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II classification with lack of sterility assurance in a neonatal IV product. No illnesses or injuries reported. Score reflects high risk-of-harm potential for vulnerable neonatal patients without documented adverse events.
Plain-English summary
Central Admixture Pharmacy Services, Inc. is recalling 92 bags of Neonatal TPN Starter Bag (Amino Acids [trophamine] 3.5%/Dextrose 10% with Heparin) in 250-milliliter IV bags. The affected lot is 36-262161 with expiration date 8/21/2023. This product is used for intravenous nutrition in neonatal patients.
The recall was issued due to lack of assurance of sterility. The manufacturer lacks validation data for sanitization cycles, meaning there is no documented evidence that the manufacturing environment met required sterility standards. This creates a potential risk of microbial contamination of the product.
The affected lot was distributed nationwide in the United States. Healthcare facilities and practitioners that received this product are advised to stop using it and contact the manufacturer for replacement or return instructions.
The recalled product
- Product
- Neonatal TPN Starter Bag, Amino Acids (trophamine) 3.5%/Dextrose 10% with HEPARIN, IV Bag, total volume = 250mL, Rx only, Central Admixture Pharmacy Services, Inc., 2200 South 43rd Avenue, Pheonix, AZ 85043, NDC: 72196-0431-1
- Manufacturer
- Central Admixture Pharmacy Services, Inc.
- Category
- Drug — Parenteral Nutrition
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot# 36-262161
- Exp 8/21/2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27